HK Chopra Senior Consultant Cardiologist, Medanta–Moolchand Heart Institute, New Delhi, India; Chairman, CME, Moolchand MedcityNavin C Nanda Distinguished Professor, Department of Medicine and Cardiovascular Disease, University of Alabama at Birmingham, Alabama, USAJagat Narula Executive Vice President, Chief Academic Officer, UT Health, Houston, Texas, USA ; President-Elect, World Heart FederationGS Wander Professor and Head of Cardiology, Hero DMC Heart Institute, Dayanand Medical College and Hospital, Ludhiana, Punjab, India; Past President, APIViveka Kumar Principal Director and Chief of Cath Labs, Pan Max Hospitals, Max Heart and Vascular Institute, Saket, New Delhi, IndiaCN Manjunath Professor of Cardiology, Director, Sri Jayadeva Institute of Cardiovascular Sciences and Research, Bangalore, Karnataka, IndiaCK Ponde Head, Department of Cardiology, PD Hinduja National Hospital, Mumbai, Maharashtra, India; Past President, IAEAK Pancholia Head, Department of Clinical and Preventive Cardiology, Arihant Hospital, Indore, Madhya Pradesh, India

• SECTION 1: CLINICALSECTION 2: DIAGNOSISSECTION 3: TENECTEPLASE (TNK) AND CLOT TREATMENTSECTION 4: NOACs IN CLOT TREATMENTSECTION 5: THROMBOSIS AND CORONARY ARTERY DISEASESECTION 6: THROMBOSIS AND HYPERTENSIONSECTION 7: THROMBOSIS AND HEART FAILURESECTION 8: THROMBOSIS AND DYSLIPIDEMIASECTON 9: THROMBOSIS AND DIABETES MELLITUSSECTION 10: THROMBOSIS AND ARRHYTHMIASECTION 11: THROMBOSIS AND CARDIOMYOPATHYSECTION 12: THROMBOSIS AND RHDSECTION 13: DVTSECTION 14: THROMBOSIS AND PADSECTION 15: THROMBOSIS AND CAROTID ARTERY DISEASESECTION 16: THROMBOSIS AND VERTEBRAL ARTERY DISEASESECTION 17: THROMBOSIS AND STROKE INTRACEREBRAL ARTERIAL DISEASESECTION 18: THROMBOSIS AND KIDNEYSECTION 19: THROMBOSIS AND CARDIAC SURGERYSECTION 20: THROMBOSIS AND CRITICAL CARESECTION 21: THROMBOSIS IN EMERGENCY AND URGENT CARESECTION 22: THROMBOSIS AND SEPSISSECTION 23: THROMBOSIS AND WOMENSECTION 24: THROMBOSIS AND EYESECTION 25: THROMBOSIS AND LUNGSECTION 26: NOAC AND DRUGS INTERACTIONSECTION 27: COVID-INFLICTED COAGULOPATHYSECTION 28: CLOT IN ECMOSECTION 29: THROMBOSIS AND COVID VACCINATIONSECTION 30: THROMBOSIS AND NUTRITIONSECTION 31: CARDIO-ONCOLOGY AND THROMBOSISSECTION 32: POSTMITRAL CLIP THROMBOSISSECTION 33: PEDIATRICS AND THROMBOSISSECTION 34: SKIN AND THROMBOSISSECTION 35: THROMBOSIS AND AVNSECTION 36: FUTURE DIRECTIONS IN THROMBOSIS CARE

HK Chopra Senior Consultant Cardiologist, Medanta–Moolchand Heart Institute, New Delhi, India; Chairman, CME, Moolchand MedcityNavin C Nanda Distinguished Professor, Department of Medicine and Cardiovascular Disease, University of Alabama at Birmingham, Alabama, USAJagat Narula Executive Vice President, Chief Academic Officer, UT Health, Houston, Texas, USA ; President-Elect, World Heart FederationGS Wander Professor and Head of Cardiology, Hero DMC Heart Institute, Dayanand Medical College and Hospital, Ludhiana, Punjab, India; Past President, APIViveka Kumar Principal Director and Chief of Cath Labs, Pan Max Hospitals, Max Heart and Vascular Institute, Saket, New Delhi, IndiaCN Manjunath Professor of Cardiology, Director, Sri Jayadeva Institute of Cardiovascular Sciences and Research, Bangalore, Karnataka, IndiaCK Ponde Head, Department of Cardiology, PD Hinduja National Hospital, Mumbai, Maharashtra, India; Past President, IAEAK Pancholia Head, Department of Clinical and Preventive Cardiology, Arihant Hospital, Indore, Madhya Pradesh, India

• SECTION 1: CLINICALSECTION 2: DIAGNOSISSECTION 3: TENECTEPLASE (TNK) AND CLOT TREATMENTSECTION 4: NOACs IN CLOT TREATMENTSECTION 5: THROMBOSIS AND CORONARY ARTERY DISEASESECTION 6: THROMBOSIS AND HYPERTENSIONSECTION 7: THROMBOSIS AND HEART FAILURESECTION 8: THROMBOSIS AND DYSLIPIDEMIASECTON 9: THROMBOSIS AND DIABETES MELLITUSSECTION 10: THROMBOSIS AND ARRHYTHMIASECTION 11: THROMBOSIS AND CARDIOMYOPATHYSECTION 12: THROMBOSIS AND RHDSECTION 13: DVTSECTION 14: THROMBOSIS AND PADSECTION 15: THROMBOSIS AND CAROTID ARTERY DISEASESECTION 16: THROMBOSIS AND VERTEBRAL ARTERY DISEASESECTION 17: THROMBOSIS AND STROKE INTRACEREBRAL ARTERIAL DISEASESECTION 18: THROMBOSIS AND KIDNEYSECTION 19: THROMBOSIS AND CARDIAC SURGERYSECTION 20: THROMBOSIS AND CRITICAL CARESECTION 21: THROMBOSIS IN EMERGENCY AND URGENT CARESECTION 22: THROMBOSIS AND SEPSISSECTION 23: THROMBOSIS AND WOMENSECTION 24: THROMBOSIS AND EYESECTION 25: THROMBOSIS AND LUNGSECTION 26: NOAC AND DRUGS INTERACTIONSECTION 27: COVID-INFLICTED COAGULOPATHYSECTION 28: CLOT IN ECMOSECTION 29: THROMBOSIS AND COVID VACCINATIONSECTION 30: THROMBOSIS AND NUTRITIONSECTION 31: CARDIO-ONCOLOGY AND THROMBOSISSECTION 32: POSTMITRAL CLIP THROMBOSISSECTION 33: PEDIATRICS AND THROMBOSISSECTION 34: SKIN AND THROMBOSISSECTION 35: THROMBOSIS AND AVNSECTION 36: FUTURE DIRECTIONS IN THROMBOSIS CARE

HK Chopra Senior Consultant Cardiologist, Medanta–Moolchand Heart Institute, New Delhi, India; Chairman, CME, Moolchand MedcityNavin C Nanda Distinguished Professor, Department of Medicine and Cardiovascular Disease, University of Alabama at Birmingham, Alabama, USAJagat Narula Executive Vice President, Chief Academic Officer, UT Health, Houston, Texas, USA ; President-Elect, World Heart FederationGS Wander Professor and Head of Cardiology, Hero DMC Heart Institute, Dayanand Medical College and Hospital, Ludhiana, Punjab, India; Past President, APIViveka Kumar Principal Director and Chief of Cath Labs, Pan Max Hospitals, Max Heart and Vascular Institute, Saket, New Delhi, IndiaCN Manjunath Professor of Cardiology, Director, Sri Jayadeva Institute of Cardiovascular Sciences and Research, Bangalore, Karnataka, IndiaCK Ponde Head, Department of Cardiology, PD Hinduja National Hospital, Mumbai, Maharashtra, India; Past President, IAEAK Pancholia Head, Department of Clinical and Preventive Cardiology, Arihant Hospital, Indore, Madhya Pradesh, India

• SECTION 1: CLINICALSECTION 2: DIAGNOSISSECTION 3: TENECTEPLASE (TNK) AND CLOT TREATMENTSECTION 4: NOACs IN CLOT TREATMENTSECTION 5: THROMBOSIS AND CORONARY ARTERY DISEASESECTION 6: THROMBOSIS AND HYPERTENSIONSECTION 7: THROMBOSIS AND HEART FAILURESECTION 8: THROMBOSIS AND DYSLIPIDEMIASECTON 9: THROMBOSIS AND DIABETES MELLITUSSECTION 10: THROMBOSIS AND ARRHYTHMIASECTION 11: THROMBOSIS AND CARDIOMYOPATHYSECTION 12: THROMBOSIS AND RHDSECTION 13: DVTSECTION 14: THROMBOSIS AND PADSECTION 15: THROMBOSIS AND CAROTID ARTERY DISEASESECTION 16: THROMBOSIS AND VERTEBRAL ARTERY DISEASESECTION 17: THROMBOSIS AND STROKE INTRACEREBRAL ARTERIAL DISEASESECTION 18: THROMBOSIS AND KIDNEYSECTION 19: THROMBOSIS AND CARDIAC SURGERYSECTION 20: THROMBOSIS AND CRITICAL CARESECTION 21: THROMBOSIS IN EMERGENCY AND URGENT CARESECTION 22: THROMBOSIS AND SEPSISSECTION 23: THROMBOSIS AND WOMENSECTION 24: THROMBOSIS AND EYESECTION 25: THROMBOSIS AND LUNGSECTION 26: NOAC AND DRUGS INTERACTIONSECTION 27: COVID-INFLICTED COAGULOPATHYSECTION 28: CLOT IN ECMOSECTION 29: THROMBOSIS AND COVID VACCINATIONSECTION 30: THROMBOSIS AND NUTRITIONSECTION 31: CARDIO-ONCOLOGY AND THROMBOSISSECTION 32: POSTMITRAL CLIP THROMBOSISSECTION 33: PEDIATRICS AND THROMBOSISSECTION 34: SKIN AND THROMBOSISSECTION 35: THROMBOSIS AND AVNSECTION 36: FUTURE DIRECTIONS IN THROMBOSIS CARE